Business Context and Reporting Period
Company: Intensity Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 23, 2026
Reporting Period: Event date March 23, 2026
The Company, an emerging growth company incorporated in Delaware, filed this report to disclose an update to its capital raising capabilities.
Key Financial Metrics
This filing does not contain audited financial statements, revenue, profit, cash flow, or debt metrics. The only financial figure disclosed relates to the capacity of a financing facility:
- ATM Program Capacity: Increased to $60.0 million.
- Shares Issued: None (the Company is under no obligation to issue shares).
Material Changes
The primary material change is the expansion of the Company's existing "at-the-market" (ATM) offering program:
- Previous Capacity: Not explicitly stated in this text, but the program was previously established under an agreement dated July 3, 2024.
- New Capacity: The aggregate amount of common stock that may be issued under the Offering Agreement has been increased to $60.0 million.
- Purpose: To enhance financial flexibility and provide an efficient mechanism to access capital based on market conditions and strategic priorities.
Guidance, Outlook, and Risks
Management Commentary: The Company stated that any utilization of the ATM will be at its discretion. The expanded facility is intended to provide flexibility, but there is no assurance that the Sales Agent (H.C. Wainwright & Co. LLC) will be able to complete future placements even if instructed.
Risks and Contingencies:
- Market Dependency: The number of shares ultimately sold will fluctuate based on the market price of common stock, sales limits set by the Company, and market demand.
- No Obligation: The Company is under no obligation to issue any shares pursuant to the program.
Investor Verification Checklist
- Verify the previous capacity of the ATM program prior to this $60.0 million increase to understand the magnitude of the expansion.
- Review the original Offering Agreement dated July 3, 2024, for terms regarding the Sales Agent's commission and any restrictions on sales.
- Monitor subsequent filings to determine if the Company actually utilizes the ATM facility to raise capital.
- Check the Company's most recent 10-Q or 10-K for current cash balances and burn rate to assess the immediate necessity of utilizing this facility.